NAVIDEA BIOPHARMACEUTICALS, INC. Defined Contribution Plan, Cost
NAVIDEA BIOPHARMACEUTICALS, INC. reported Defined Contribution Plan, Cost of $30.75 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2023-03-27
- NAVIDEA BIOPHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2022 was $30.75K, a 79.28% decline from fiscal 2021.
- NAVIDEA BIOPHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2021 was $148.41K, a 202.87% increase from fiscal 2020.
- NAVIDEA BIOPHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2020 was $49.00K, a 250.00% increase from fiscal 2019.
- NAVIDEA BIOPHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2019 was $14.00K, a 65.00% decline from fiscal 2018.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2022-12-31 | $30.75K 10-K · filed 2023-03-27 | |
| 2021-12-31 | $148.41K 10-K · filed 2023-03-27 | $148.00K 10-K · filed 2022-03-28 |
| 2020-12-31 | $49.00K 10-K · filed 2022-03-28 | |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-26 | |
| 2018-12-31 | $40.00K 10-K · filed 2020-03-18 | |
| 2017-12-31 | $12.00K 10-K · filed 2019-03-15 | |
| 2016-12-31 | $47.00K 10-K · filed 2018-03-15 | $101.00K 10-K · filed 2017-03-31 |
| 2015-12-31 | $73.00K 10-K · filed 2018-03-15 | $124.00K 10-K · filed 2016-03-23 |
| 2014-12-31 | $83.00K 8-K · filed 2017-12-15 | $125.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | $104.00K 10-K · filed 2016-03-23 | |
| 2012-12-31 | $71.00K 10-K · filed 2015-03-16 | |
| 2011-12-31 | $56.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $37.00K 10-K/A · filed 2013-03-21 |